Your browser doesn't support javascript.
loading
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
Edupuganti, Srilatha; Mgodi, Nyaradzo; Karuna, Shelly T; Andrew, Philip; Rudnicki, Erika; Kochar, Nidhi; deCamp, Allan; De La Grecca, Robert; Anderson, Maija; Karg, Carissa; Tindale, India; Greene, Elizabeth; Broder, Gail B; Lucas, Jonathan; Hural, John; Gallardo-Cartagena, Jorge A; Gonzales, Pedro; Frank, Ian; Sobieszczyk, Magdalena; Gomez Lorenzo, Margarita M; Burns, David; Anderson, Peter L; Miner, Maurine D; Ledgerwood, Julie; Mascola, John R; Gilbert, Peter B; Cohen, Myron S; Corey, Lawrence.
Afiliación
  • Edupuganti S; Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA.
  • Mgodi N; University of Zimbabwe College of Health Sciences Clinical Trials Research Centre, Harare, Zimbabwe.
  • Karuna ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Andrew P; Institute for Global Health and Infectious Disease, University of North Carolina, Chapel Hill, NC.
  • Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Kochar N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • deCamp A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • De La Grecca R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Anderson M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Karg C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Tindale I; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Greene E; Institute for Global Health and Infectious Disease, University of North Carolina, Chapel Hill, NC.
  • Broder GB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Lucas J; Institute for Global Health and Infectious Disease, University of North Carolina, Chapel Hill, NC.
  • Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Gallardo-Cartagena JA; Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Peru.
  • Gonzales P; Servicio de Enfermedades Infecciosas y Tropicales, Hospital Nacional Dos de Mayo, Lima.
  • Frank I; Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Pennsylvania, PA.
  • Sobieszczyk M; Department of Medicine, Division of Infectious Diseases, Columbia University, New York, NY.
  • Gomez Lorenzo MM; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Burns D; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Anderson PL; Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Miner MD; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.
  • Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
  • Cohen MS; Department of Biostatistics, Univeristy of Washington, Seattle, WA.
  • Corey L; Institute for Global Health and Infectious Disease, University of North Carolina, Chapel Hill, NC.
J Acquir Immune Defic Syndr ; 87(1): 671-679, 2021 05 01.
Article en En | MEDLINE | ID: mdl-33587505
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / Anticuerpos Neutralizantes / Anticuerpos ampliamente neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Brasil / Europa / Peru Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2021 Tipo del documento: Article País de afiliación: Gabón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / Anticuerpos Neutralizantes / Anticuerpos ampliamente neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / America do sul / Brasil / Europa / Peru Idioma: En Revista: J Acquir Immune Defic Syndr Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2021 Tipo del documento: Article País de afiliación: Gabón Pais de publicación: Estados Unidos